The Institute of Cancer Research, London’s Enterprise Unit played host to scientists and possible future partners from the commercial sector to discuss opportunities to work together to defeat cancer.

Details of a major new online resource designed to improve biomedical research by helping researchers choose the best chemical probes for their experiments – allowing drug targets to be validated much more effectively – have been published today.

Scientists have created a map of all 1,578 licensed drugs and their mechanisms of action – as a means of identifying ‘uncharted waters’ in the search for future treatments.